Development of Chimeric Antigen Receptor Phagocytes Against Glioblastoma

$4.48M USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	University of Colorado Denver
Country	United States
Start Date	Jul 01, 2024
End Date	Jun 30, 2029
Duration	1,825 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10937869`

Grant Description

Project Abstract: Pediatric HGGs comprise glioblastoma [glioblastoma multiforme (GBM)], anaplastic astrocytoma, and diffuse intrinsic pontine glioma (DIPG) and collectively are the most common malignant brain tumors in children. Patients with HGGs have a very dismal prognosis, with